Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Eye fundus destruction and type II muscle fiber atrophy in gyrate atrophy of the choroid and retina with hyperornithinaemia (GA) may be mediated by elevated ornithine concentrations which strongly inhibit creatine biosynthesis. This results in deficiency of creatine phosphate (PCr), a key intracellular energy source, as we have demonstrated in skeletal muscle of the patients by 31 P magnetic resonance spectroscopy (31 P MRS). Materials and methods: Possible correction of the relative PCr deficiency by long‐term daily exogenous supplementation of creatine or its precursors was investigated in four GA patients receiving creatine and in five patients treated with guanidinoacetic acid‐methionine combination. The relative PCr concentration, expressed as PCr/P i (P i; inorganic phosphate) or as PCr/ATP ratios, was compared with the values of untreated GA patients, and matched healthy volunteers. Results: Muscle PCr/Pi ratios (mean ± SD) of the untreated and creatine supplemented GA patients and controls were 4.9 ± 1.4, 7.9 ± 0.4 and 8.4 ± 1.3. Guanidinoacetate‐methionine combination was similarly effective (respective PCr/Pi ratios: 4.9 ± 0.7, 6.3 ± 1.1 and 10.7 ± 2.8). Conclusion: Supplementation with creatine or creatine precursors almost normalised low muscle PCr/Pi ratios of patients with GA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi
Kushmerick, M. J., Moerland, T. S., & Wiseman, R. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7521 · Cited by 301
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina
Sipilä, I., Rapola, J., Simell, O., & Vannas, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104093041503 · Cited by 181
Gyrate Atrophy of the Choroid and Retina
Vannas-Sulonen, K., Sipilä, I., Vannas, A., Simell, O., & Rapola, J. (1985) · Ophthalmology · doi:10.1016/s0161-6420(85)34098-8 · Cited by 124
Guanidinoacetate methyltransferase deficiency: New clinical features
Ganesan, V., Johnson, A., Connelly, A., Eckhardt, S., & Surtees, R. A. H. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00083-0 · Cited by 108
Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia
Näntö–Salonen, K., Komu, M., Lundbom, N., Heinänen, K., Alanen, A., Sipilä, I., & Simell, O. (1999) · Neurology · doi:10.1212/wnl.53.2.303 · Cited by 63
Heinänen, Näntö‐Salonen, Komu, Erkintalo, Heinonen, Pulkki, Valtonen, Nikoskelainen, Alanen, & Simell (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00467.x · Cited by 30
Self-citation
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate
Persky, A. M., & Brazeau, G. A. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01490-x · Cited by 332
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Sestili, P., Martinelli, C., Bravi, G., Piccoli, G., Curci, R., Battistelli, M., Falcieri, E., Agostini, D., Gioacchini, A. M., & Stocchi, V. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.035 · Cited by 220
Metadata
- Authors
- Heinänen, Näntö‐Salonen, Komu, Erkintalo, Alanen, Heinonen, Pulkki, Nikoskelainen, Sipilä, & Simell
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 29
- Issue
- 12
- Pages
- 1060-1065
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2150098487
- Cited by
- 57
- References
- 8
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia. https://app.cochat.ai/papers/10.1046/j.1365-2362.1999.00569.x
- The paper
- Heinänen, Näntö‐Salonen, Komu, Erkintalo, Alanen, Heinonen, Pulkki, Nikoskelainen, Sipilä, & Simell. (1999). Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.1999.00569.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.